My role seeks to provide a significant scientific contribution towards the evaluation and communication of important medical information related to the hematology field. This is a key strategic role for the medical team in AstraZeneca.

- Commercial and Market Access executive with expertise in Hemophilia.- In charge of orchestrating the commercialization of an innovative pharmaceutical product in Chile through close links and direct involvement with access and commercial departments.- Coordination of relevant medical education.- Customer-facing role with health care providers, health insurance companies or other stakeholders as patients’ aggrupation and The National Health Fund.

Scientific advisor in the hemophilia area for Roche Chile and Roche Uruguay for the South Cluster Hemophilia team.

A field-based advisor that acts as a resource for medical specialists and investigators delivering scientific information at request, in accordance to local laws, regulations and codes according to Roche’s policies.

Functional Materials . Corrosion and Biocorrosion Protection.

He trabajado en la formación profesional de ingenieros en la Universidad de Santiago. He impartido clases de bioquímica y de biología con la visión de nivelar conocimientos en áreas biológicas para ingeniería. Este desafío me ha traído mucha satisfacción, ya que al terminar el semestre los futuros ingenieros pueden manejar conceptos biológicos básicos.

Grupo Sibi es una compañía dedicada a la entrega de soluciones integrales basadas en innovación biotecnológica, su foco principal es el desarrollo de proyectos y asesorías a empresas que permitan optimizar procesos críticos, mejorar el rendimiento de áreas clave dentro del sector industrial en el cual se desempeñan nuestros clientes y aportar a los procesos de transferencia tecnológica.

ELISA test for animal vaccine design and production. Also, I worked on a small data analysis project to develop vaccines from a molecular-based approach. Our group estimated that my approach contributed to making a decision about which vaccine approach could be meet the expectations of the company.